Precipio Investor Relations Material
Latest events
Q1 2025
Precipio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Precipio Inc
Access all reports
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. The company delivers liquid biopsy products for the detection of genomic biomarkers, such as cell-free DNA (cfDNA) extracted from patient blood. Its integrated liquid biopsy platform combines proprietary CFDNA extraction and enrichment technology with third party sample preparation to enable the detection of tumor-specific cfDNA in multiple end-user clinical applications. The company is also involved in development of novel diagnostic products at its laboratories in Tempe and San Diego, California. Precipio, Inc. is based in San Diego, California.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PRPO
Country
🇺🇸 United States